| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 02/22/2007 | CA2619262A1 Pyrazolone derivatives for the treatment of tuberculosis |
| 02/22/2007 | CA2619249A1 Benzoquinazoline derivatives and their use in treating bone disorders |
| 02/22/2007 | CA2619223A1 Fluoro substituted 2-oxo azepan derivatives |
| 02/22/2007 | CA2619010A1 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/22/2007 | CA2618747A1 Substituted imidazole compounds as ksp inhibitors |
| 02/22/2007 | CA2618724A1 Imidazole compounds that modulate hsp90 activity |
| 02/22/2007 | CA2618451A1 Amide derivatives |
| 02/22/2007 | CA2618377A1 Pyrazole compounds that modulate hsp90 activity |
| 02/22/2007 | CA2618340A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/22/2007 | CA2616307A1 Substituted piperazines as metabotropic glutamate receptor antagonists |
| 02/22/2007 | CA2608245A1 Process for the preparation of losartan potassium |
| 02/21/2007 | EP1754711A1 Process for producing indolopyrrolocarbazole derivative |
| 02/21/2007 | EP1754703A2 N-Heterocyclic derivatives as nos inhibitors |
| 02/21/2007 | EP1753758A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 02/21/2007 | EP1753757A1 Substituted 2,5-diaminomethyl-1h-pyrroles |
| 02/21/2007 | EP1753748A1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors |
| 02/21/2007 | EP1753747A1 5,6-diphenyl-1,2,4-triazinic dimeric derivatives and the use thereof in the form of sun-protective agents |
| 02/21/2007 | EP1753746A2 Novel pyrrole derivatives with angiotensin ii antagonist activity |
| 02/21/2007 | EP1753745A2 Pyrazinylmethyl lactam derivatives |
| 02/21/2007 | EP1753744A1 Prodrugs of pyrrolylpyrimidine erk protein kinase inhibitors |
| 02/21/2007 | EP1753743A1 Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals |
| 02/21/2007 | EP1753735A1 Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators |
| 02/21/2007 | EP1753731A2 Pyrimidin-4-one derivatives and their use as p38 kinase modulators |
| 02/21/2007 | EP1753727A1 Novel cis-imidazolines |
| 02/21/2007 | EP1753719A1 Substituted pyrrolidine-2-ones |
| 02/21/2007 | EP1753718A1 3-amino-2-phenylpyrrolidine derivatives |
| 02/21/2007 | EP1753421A2 Arylsulfonamides and uses as hydroxysteroid dehydrogenase |
| 02/21/2007 | EP1567488B1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | EP0968193B1 Phenylsulphonyl ureas, processes for their preparation and their use as herbicides and plant-growth regulators |
| 02/21/2007 | CN1918148A Substituted benzimidazoles and their use for inducing apoptosis |
| 02/21/2007 | CN1918137A Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
| 02/21/2007 | CN1918131A Novel inhibitors of glutaminyl cyclase |
| 02/21/2007 | CN1918128A Fused ring 4-oxopyrimidine derivative |
| 02/21/2007 | CN1917921A Calcitonin gene related peptide receptor antagonists |
| 02/21/2007 | CN1917881A Novel phenylalanine derivatives |
| 02/21/2007 | CN1917880A Pyrimidines with tie2 (tek) activity |
| 02/21/2007 | CN1917873A Diurea derivatives |
| 02/21/2007 | CN1915991A Synthesis of indole thiazole compounds as ligands for the ah receptor |
| 02/21/2007 | CN1915990A Method for preparingLosartan |
| 02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 02/20/2007 | US7179910 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
| 02/20/2007 | US7179907 3-amino-2-oxo-azetidin-1-yl) acetic acid derivatives with anti-PBP2a activity; providing a monobactam core alkyne,reacting monobactam alkyne under conditions that promote cyclotrimerization, performing a Diels-Alder reaction between the cyclotrimerization product of b) and a diene reactant |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 02/20/2007 | US7179831 Hydantoin derivatives; for treatment of asthma, chronic obstructive pulmonary diseases (COPD), arthritis, cancer, heart disease and nephritis |
| 02/20/2007 | US7179825 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179822 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 02/20/2007 | US7179815 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 02/20/2007 | US7179807 5-substituted-2-arylpyrazines |
| 02/20/2007 | US7179806 Δ1-pyrrolines used as pesticides |
| 02/20/2007 | US7179805 Microbiocides; bactericides |
| 02/20/2007 | US7179804 Tachykinin receptor antagonists |
| 02/20/2007 | US7179802 reducing the risk of developing a condition selected from the group consisting of hypercholesterolemia, atherosclerosis, low HDL levels, high LDL levels, hyperlipidemia, hypertriglyceridemia and dyslipidemia |
| 02/20/2007 | CA2455050C Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole-3-ylidene) methyl]-2, 4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
| 02/20/2007 | CA2371174C Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 02/20/2007 | CA2344574C Thyroid receptor ligands |
| 02/20/2007 | CA2119745C Nonpeptidyl integrin inhibitors having specificity for gpiibiiia receptor |
| 02/20/2007 | CA2085192C Fungicidal derivatives of 2-imidazoline-5-ones and 2-imidazoline-5-thiones |
| 02/15/2007 | WO2007019416A1 Benzimidazole derivatives as sirtuin modulators |
| 02/15/2007 | WO2007018808A2 Methods and intermediates for the synthesis of porphyrins |
| 02/15/2007 | WO2007018807A2 Methods and intermediates for the synthesis of porphyrins |
| 02/15/2007 | WO2007018439A1 Conducting polymers and uses thereof |
| 02/15/2007 | WO2007018168A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | WO2007017649A1 Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes |
| 02/15/2007 | WO2007017114A1 New substituted azathymidine derivatives and their use in the treatment of bacterial infectious diseases |
| 02/15/2007 | WO2007017096A1 Pyrazine derivatives useful as adenosine receptor antagonists |
| 02/15/2007 | WO2007017083A1 Pyrazole derivatives having tyrosinkinase activity |
| 02/15/2007 | WO2007016784A1 Novel substituted 1,2,3-tπazolylmethyl-benzothiophene or -indole and their use as leukotπene biosynthesis inhibitors |
| 02/15/2007 | WO2006136829A3 Pyrazole derivatives and their use as pka and pkb modulators |
| 02/15/2007 | WO2006135649A3 Aminoquinoline and aminoquinazoline kinase modulators |
| 02/15/2007 | WO2006133242A3 Azinone and diazinone v3 inhibitors for depression and stress disorders |
| 02/15/2007 | WO2006130297A3 Solid forms of 1-( 5-(ih-i , 2 , 4 -triazol- 5 -yl)(1h-indazol-3-yl))-3-(2-piperidylethoxy)benzene |
| 02/15/2007 | WO2006067614B1 Heteroaromatic derivatives useful as anticancer agents |
| 02/15/2007 | WO2005123703A8 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 02/15/2007 | US20070037986 reacting N-methyl-o-phenylenediamine with 2-propyl-4-methyl-1H-benzimidazole-6-carboxylic acid, coupling and cyclization is achieved using 1,3,5-triazine ( 2-chloro-4,6-dimethoxy-1,3,5-triazine) and tertiary amine ( morpholine, N-methyl-) |
| 02/15/2007 | US20070037974 Inhibitors of P2X3 |
| 02/15/2007 | US20070037973 reacting a cyclic alpha , beta -unsaturated ketone compound with a nitroso compound in the presence of a proline-based catalyst to provide 7-Phenyl-6-oxa-7-aza-bicyclo[3.2.2]nonan-9-one or derivatives; catalytic asymmetric O-nitroso Aldol/Michael reaction |
| 02/15/2007 | US20070037865 Sirtuin modulating compounds |
| 02/15/2007 | US20070037856 Pyrrole-Type compounds, compositions and methods for treating cancer or viral disease |
| 02/15/2007 | US20070037854 Process for preparing sulfonamide-containing indole compounds |
| 02/15/2007 | US20070037853 N-(3-aminopropyl)-N-{1-[1-benzyl-4-(3-chlorophenyl)-1H-imidazol-2-yl]-2-methylpropyl}morpholine-4-carboxamide and derivatives; kinesin spindle protein (KSP) inhibitors; anticarcinogenic agents; antimiotic; gene expression inhibition |
| 02/15/2007 | US20070037852 Migrastatin analogs and uses thereof |
| 02/15/2007 | US20070037847 Intrathecal administering of LY293558 or 6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinolone-3-carboxylic acid; side effect reduction |
| 02/15/2007 | US20070037839 useful in Pharmaceutical medicines or pharmacological tools; cytostatic agents; antiproliferative/antineoplastic agents; 2-Anilino-4-[1-isopropyl-2-(hydroxyiminomethyl)imidazol-5-yl]pyrimidine; rheumatoid arthritis; breast cancer |
| 02/15/2007 | US20070037836 Melanin concentrating hormone; obesity and related disorders, anxiety, or depression; trans-4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide |
| 02/15/2007 | US20070037826 Indolylmaleimide derivatives |
| 02/15/2007 | US20070037819 Treating chronic neuropathic or inflammatory pain; [(1-methyl-1H-pyrrol-2-yl)methyl][[1-[(4-pyrazin-2-ylpiperazin-1-yl)acetyl]-4-[3-trifluoromethyl)phenyl]piperid-4-yl]methyl]amine |
| 02/15/2007 | US20070037814 ACYLSULFAMIDE INHIBITORS OF FACTOR VIIa |
| 02/15/2007 | US20070037811 Hiv inhibiting 1,2,4-triazines |
| 02/15/2007 | US20070037808 Anti-inflammatory medicaments |
| 02/15/2007 | US20070037806 Pyrrolidine derivatives as oxytocin antagonists |
| 02/15/2007 | US20070037803 Benzimidazole derivatives |
| 02/15/2007 | US20070037802 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/15/2007 | US20070037801 Novel indoles are cannabinoid receptor ligands |
| 02/15/2007 | US20070037796 e.g. 7-Phenyl-isoquinoline-5-sulfonic acid {2-[3 -(4-nitrophenyl)-propylamino]-ethyl}-amide, dihydrochloride salt; antiviral, antineoplastic, anticarcinogenic agents; neoplasms |
| 02/15/2007 | US20070037794 Heteroaryl sulfonamides and CCR2 |
| 02/15/2007 | US20070037788 5-(3,8-Difluoro-6H-dibenzo[b,e]oxepin-11-ylidenemethyl)-1-(1-ethyl-pyrrolidin-3-yl) -1,3-dihydro-benzoimidazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia |
| 02/15/2007 | US20070037787 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |